Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
January 12, 2016 Interpretation of verbal descriptors for response options commonly used in verbal rating scales in patient-reported outcome instruments
April 11, 2016 Electronic Capture of Clinical Outcome Assessment Data: Why Is It Not Used More in Clinical Studies
CDISC, C-Path, and TransCelerate Announce Therapeutic Area Standard for Kidney Transplant November 2, 2016 CDISC, C-Path, and TransCelerate Announce Therapeutic Area Standard for Kidney Transplant TUCSON, A
US Food and Drug Administration Awards Critical Path Institute Three Grants, One Contract November 1, 2016 US Food and Drug Administration Awards Critical Path Institute Three Grants, One Contract TUCSON, A
Critical Path Institute and CHDI Foundation, Inc., establish a consortium to expedite approval of Huntington’s disease therapeutics Oct 31, 2016 Critical Path Institute and CHDI Foundation, Inc., establish a consortium to expedite approval of Hunti
December 3, 2015 Ensuring Equivalence of Electronic and Paper Administration of Patient-Reported Outcome Measures This webinar provides an overview of scientific and regulatory considerations when migrating paper-based patient-reported outcome
TB-ReFLECT: A Collaborative Effort to Enhance TB Clinical Research Oct 25, 2016 TB-ReFLECT: A Collaborative Effort to Enhance TB Clinical Research TUCSON, Ariz., October 25, 2016 —
October 24, 2016 Advancing Tuberculosis Drug Regimen Development through Innovative Quantitative Translational Pharmacology Methods and Approaches